Announcements Trials
Browse Landscape

Phase

Phase 2 15Phase 3 3Phase 1/2 2Phase 1 2Phase 4 1

Status

Completed 3

Sponsor Class

INDUSTRY 3OTHER 2

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 2Plasma cell 1

Conditions

Lymphoma, Non-Hodgkin 2Multiple Myeloma 1

Interventions

Carboplatin 315Paclitaxel 303Cisplatin 250Docetaxel 238pembrolizumab 230Gemcitabine 214Pemetrexed 158Capecitabine 147Rituximab 144Bevacizumab 142Dexamethasone 125Fluorouracil 121Cyclophosphamide 102Trastuzumab 100Doxorubicin 96Nivolumab 93Prednisone 92Oxaliplatin 90atezolizumab 75Leucovorin 72durvalumab 69130-nm albumin-bound paclitaxel 68Injections 66Lenalidomide 63Irinotecan 62Bortezomib 56Letrozole 54Topotecan 53Fulvestrant 53Drug Therapy 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × INDUSTRY × plerixafor × Clear all
NCT01767714 2014-12-09

Evaluation of Plerixafor Plus G-CSF to Mobilize and Collect 5×10^6CD34+ Cells/kg in Non-Hodgkin's Lymphoma (NHL) Patients for Autologous Transplantation

Sanofi

Phase 3 Completed
100 enrolled
Lymphoid

Lymphoma, Non-Hodgkin

NCT00103610 2014-03-13

Mobilization of Stem Cells With AMD3100 (Plerixafor) in Non-Hodgkin's Lymphoma Patients

Sanofi

Phase 3 Completed
298 enrolled 16 charts
Lymphoid

Lymphoma, Non-Hodgkin

NCT00103662 2014-03-13

Mobilization of Stem Cells With AMD3100 (Plerixafor) in Multiple Myeloma Patients

Sanofi

Phase 3 Completed
302 enrolled 17 charts
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡